Provencio M, Ortega AL, Coves-Sarto J, Calvo V, et al. Atezolizumab Plus Bevacizumab as First-line Treatment for Patients With Metastatic Nonsquamous Non-Small Cell Lung Cancer With High Tumor Mutation Burden: A Nonrandomized Controlled Trial. JAMA Oncol 2022 Dec 15. doi: 10.1001/jamaoncol.2022.5959.
PMID: 36520426